B-ALL | opacc

New study achieves 99 percent remission in children who relapse with most common childhood cancer

A recent collaboration with colleagues in Shanghai Children’s Medical Center has found a new immunotherapy combination that resulted in ...

Study identifies chromosomal abnormalities associated with relapse in frequent subtype of childhood

An international research team coordinated by Dr. Oscar Molina and Dr. Pablo Menéndez, from the Josep Carreras Leukaemia Research ...

Exploiting a vulnerability in an aggressive leukemia affecting babies

New work finds that the cells that cause relapse in MLL-rearranged B-ALL can morph between two states, and that targeting one of these...

Research lays a foundation for prevention of the most common childhood cancer

Scientists at St. Jude Children’s Research Hospital and the Cancer Research Center in Spain blocked development of acute lymphoblastic...

Immunotherapy drug improves outcomes for some children with relapsed leukemia

New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for...

Intensive Treatment May Pose Fertility Risks in Childhood Cancer Survivors

They survived childhood cancer. But the disease has taken a toll on their mental health.

How you can support a parent who has a child with cancer

Developing ‘kinder’ treatments for a devastating childhood cancer

Breakthrough as new drug promises to shield child cancer patients from hearing loss

Study finds higher breast cancer risk after certain forms of childhood cancer treatment

Aggressive Cancer Cells Transformed Into Healthy Cells in Breakthrough

Cardiac RT May Amplify Late Disease Risk in Pediatric Cancer Survivors

Are Cannabis-Based Medicines Safe for Children With Cancer?

Homoharringtonine May be ‘Better Alternative’ to Etoposide In Pediatric AML